Published in AIDS Weekly, September 4th, 2000
"Context A syndrome of lipodystrophy, characterized by fat redistribution and insulin resistance, has been estimated to affect the majority of HIV infected individuals who are treated with combination antiretroviral therapy," stated C. Hadigan and colleagues, Massachusetts General Hospital, Massachusetts. "There are no proven therapies for the metabolic disturbances associated with HIV lipodystrophy syndrome."
The researchers conducted a randomized, double-blind, placebo-controlled pilot study, therefore, assessing safety and efficacy of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.